Beatriz Moreira-Pinto

Ms. Beatriz Moreira-Pinto

University of Porto - Faculty of Pharmacy
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2021 in Antioxidants
Verified
Journal Article
Open access
PDF file
Beatriz Moreira-PintoBeatriz Moreira-Pinto
Beatriz Moreira-Pinto
LCLia Costa
Lia Costa
EFEduarda Felgueira
Eduarda Felgueira
BFBruno Fonseca
Bruno Fonseca
IRIrene Rebelo
Irene Rebelo
Resveratrol is a phytoalexin present in plant-derived foods, including grape’s skin, cocoa, and peanuts. Evidence suggests that it has beneficial effects on human health because of its antioxidant properties. However, there is limited knowledge about the part played by resveratrol in ovarian function. In this paper, the influence of resveratrol on granulosa cells (GC) was evaluated. In addition to being the main estradiol producers, GC are in direct contact with the oocyte, playing a fundamental role in its growth and development. The cell line COV434 and human granulosa cells (hGC), obtained from women undergoing assisted reproductive technology (ART), were used. GC were treated with resveratrol (0.001–20 μM) at different times (24–72 h). Low concentrations of this compound suggest a protective role, as they tend to reduce ROS/RNS formation after inducement of stress. On the contrary, high concentrations of resveratrol affect GC viability and steroidogenic function. As it may act as a direct modulator of GC oxidative balance, this work may help to clarify the impact of resveratrol on GC and the usefulness of this antioxidant as adjunct to infertility treatments.

1 August 2020 in Reproductive Toxicology
Verified
Journal Article
Closed access
Beatriz Moreira-PintoBeatriz Moreira-Pinto
Beatriz Moreira-Pinto
LCLia Costa
Lia Costa
BFBruno Fonseca
Bruno Fonseca
IRIrene Rebelo
Irene Rebelo

8 February 2021 in Reproduction, Fertility and Development
Verified
Journal Article
Closed access
PDF file
BFBruno Fonseca
Bruno Fonseca
Beatriz Moreira-PintoBeatriz Moreira-Pinto
Beatriz Moreira-Pinto
LCLia Costa
Lia Costa
EFEduarda Felgueira
Eduarda Felgueira
POPedro Oliveira
Pedro Oliveira
IRIrene Rebelo
Irene Rebelo
Although N-arachidonoylethanolamine (AEA; also known as anandamide) is present in human follicular fluid (FF), its regulation remains unknown. Therefore, the aims of the present study were to: (1) investigate the relationships between FF AEA concentrations in women undergoing assisted reproductive technology and their age, body mass index, ART characteristics and fertility treatment outcomes; and (2) assess how different inflammatory patterns may trigger AEA production by human granulosa cells (hGCs). FF AEA concentrations were higher in women undergoing IVF than in those undergoing intracytoplasmic sperm injection group. FF AEA median concentrations were lower in women undergoing ART because of male factor infertility than in women with endometriosis (1.6 vs 2.5 nM respectively), but not women with tubal, hormonal or unexplained infertility (1.6, 2.4 and 1.9 nM respectively). To evaluate the effects of macrophages on AEA production by hGCs, hGCs were cocultured with monocyte-derived macrophages. The conditioned medium from M1 polarised macrophages increased AEA production by hGCs. This was accompanied by an increase in AEA-metabolising enzymes, particularly N-acyl phosphatidylethanolamine-specific phospholipase D. The results of the present study show that high FF AEA concentrations in patients with endometriosis may be associated with the recruitment of inflammatory chemokines within the ovary, which together may contribute to the decreased reproductive potential of women with endometriosis. Collectively, these findings add a new player to the hormone and cytokine networks that regulate fertility in women.

29 March 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
MCMariana Castelôa
Mariana Castelôa
Beatriz Moreira-PintoBeatriz Moreira-Pinto
Beatriz Moreira-Pinto
Ester BenfeitoEster Benfeito
Ester Benfeito
Fernanda BorgesFernanda Borges
Fernanda Borges
BFBruno Fonseca
Bruno Fonseca
IRIrene Rebelo
Irene Rebelo
Small-cell carcinoma of the ovary of hypercalcemic type (SCCOHT) and endometrial cancer from type 1 and type 2 are gynecological tumors that affect women worldwide. The treatment encompasses the use of cytotoxic drugs that are nonspecific and inefficient. “Mitocans”, a family of drugs that specifically target tumor cells’ mitochondria, might be a solution, as they conjugate compounds, such as antioxidants, with carriers, such as lipophilic cations, that direct them to the mitochondria. In this study, caffeic acid was conjugated with triphenylphosphonium (TPP), 4-picolinium, or isoquinolinium, forming 3 new compounds (Mito6_TPP, Mito6_picol., and Mito6_isoq.) that were tested on ovarian (COV434) and endometrial (Hec50co and Ishikawa) cancer cells. The results of MTT and neutral red assays suggested a time- and concentration-dependent decrease in cell viability in all tumor cell lines. The presence of apoptosis was indicated by the Giemsa and Höechst staining and by the decrease in mitochondrial membrane potential. The measurement of intracellular reactive oxygen species demonstrated the antioxidant properties of these compounds, which might be related to cell death. Generally, Mito6_TPP was more active at lower concentrations than Mito6_picol. or Mito6_isoq., but was accompanied by more cytotoxic effects, as shown by the lactate dehydrogenase release. Non-tumorous cells (HFF-1) showed no changes after treatment. This study assessed the potential of these compounds as anticancer agents, although further investigation is needed.

31 December 2017
Verified
Book Chapter
Closed access
Beatriz Moreira-PintoBeatriz Moreira-Pinto
Beatriz Moreira-Pinto
APAndre Pires
Andre Pires